Byotrol PLC Exercise of Options & Total Voting Rights (4631M)
January 21 2021 - 4:30AM
UK Regulatory
TIDMBYOT
RNS Number : 4631M
Byotrol PLC
21 January 2021
Byotrol Plc
("Byotrol" or the "Group")
Exercise of Options and Total Voting Rights
Byotrol plc (AIM: BYOT), the anti-microbial technology company,
announces that it has allotted a total of 3,381,000 new ordinary
shares of 0.25 pence each in the capital of the Company ("Ordinary
Shares") following the exercise of options by certain employees,
all of whom are below Board level.
Application has been made for the 3,381,000 new Ordinary Shares
to be admitted to trading on AIM ("Admission") and it is expected
that Admission will become effective and trading will commence at
8.00 a.m. on 26 January 2021.
After Admission, the total number of Ordinary Shares in issue
will be 446,530,405 and the total number of voting rights will
therefore be 446,530,405. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
For further information contact:
Byotrol Plc
David Traynor, Chief Executive +44 (0)1925 742 000
Nic Hellyer, Chief Financial Officer
finnCap Limited (Nominated Adviser and
Broker) +44 (0)20 7220 0500
Geoff Nash/Kate Bannatyne - Corporate Finance
Richard Chambers - ECM
Flagstaff Strategic and Investor Communications +44 (0)20 7129 1474
Tim Thompson/Andrea Seymour/Fergus Mellon byotrol@flagstaffcomms.com
Notes to editors
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection
prevention and control company, operating globally in the
Healthcare, Industrial, Food and Consumer sectors, providing low
toxicity products with a broad-based and targeted efficacy across
all microbial classes; bacteria, viruses (including coronavirus),
fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where they can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, please go to byotrol.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEDKDBDKBKDCDB
(END) Dow Jones Newswires
January 21, 2021 05:30 ET (10:30 GMT)
Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024
Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024